Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example Ingredient/example (Narrative)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Ingredient.


Generated Narrative: Ingredient

Resource Ingredient "example"

status: active

role: ActiveBase (ingredientRole#ActiveBase)

Manufacturers

-Manufacturer
*Organization/example

substance

Codes

-Concept
*EQUIXABAN (substance#EQUIXABAN)

strength

presentation: 50 mg (Details: UCUM code mg = 'mg')/1 tablet (Details: UCUM code {tablet} = '{tablet}')

concentration: 5 mg (Details: UCUM code mg = 'mg')/1 mg (Details: UCUM code mg = 'mg')

referenceStrength

Substances

-Concept
*EQUIXABAN-SULPHATE (substance#EQUIXABAN-SULPHATE)

strength: 5.03 mg (Details: UCUM code mg = 'mg')/1 mg (Details: UCUM code mg = 'mg')


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.